While the metabolic benefits of tirzepatide are well recognised, gastrointestinal adverse events, including nausea, vomiting, constipation, and biliary disorders, have been frequently observed
Purpose-built for physicians After decades of research, we dont fully know how GLP-1s work Key takeaways: Scientists do not fully understand why response to GLP-1s varies so widely among people prescribed them
For people with type 2 diabetes, tirzepatide has demonstrated superior A1C reduction compared to GLP-1-only medications
In Vermont, semaglutide injections can be given by professionals with the titles MD, DO, NP, APRN, PA, RN, or LPN
Patients with a history of medullary thyroid carcinoma or MEN 2 syndrome should not use any GLP-1 receptor agonist
These occurrences commonly take place in the initial weeks of treatment, notably as the dosage escalates